Summary
77 / 100 · Bulios Score
What speaks for it
- Out of every 100 EUR of revenue, 29 EUR is left as net profit.
- It earns 41 EUR a year on every 100 EUR of invested capital.
- Earnings per share grew by 13% a year over the last 3 years.
- Analysts expect revenue to grow by 12% this fiscal year.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.6 EUR for 1 EUR of yearly profit. Over the last five years it was 21.1 EUR on average.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to grow by 12%. Earnings per share grew by 13% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 34 EUR
- Research and development 11 EUR
- Sales and administration 19 EUR
- Taxes and other 7.4 EUR
- Net profit 29 EUR
Net profit, industry median (Drug Manufacturers - General) 14 EUR
Out of every 100 EUR of revenue, 29 EUR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 2.23%
- Paid out of profit
- 44%
- Raised in a row
- 1 year
You receive $2.05 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.